A10BB07 • glipizide • Alimentary tract and metabolism | Blood glucose lowering drugs, excl. insulins | Sulfonylureas
Glipizide is an antidiabetic medication from the sulfonylurea class, used to control blood sugar levels in patients with type 2 diabetes. It works by stimulating the pancreas to produce more insulin, thereby helping to lower blood sugar levels.
It is recommended as part of a treatment plan that includes a balanced diet, regular physical activity, and blood sugar monitoring. Glipizide is effective in reducing the risk of diabetes-related complications, such as damage to small blood vessels (retinopathy, nephropathy).
Side effects may include hypoglycemia (excessive drop in blood sugar), nausea, dizziness, weight gain, or allergic reactions. It is important for patients to follow the prescribed dosage and watch for signs of hypoglycemia, such as shaking, sweating, or confusion.
Substance: glipizide
Date of last drug list: 01-07-2020
Commercial code: W03349001
Concentration: 5mg
Pharmaceutical form: modified release film tablets
Quantity: 30
Product type: original
Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).